PRACTICAL ONCOLOGY JOURNAL ›› 2011, Vol. 25 ›› Issue (6): 579-583.doi: 10.3969/j.issn.1002-3070.2011.06.021

Previous Articles     Next Articles

A review of KRAS gene mutation in colorectal cancer and its testing methods

WANG Dongliang,ZHANG Yanqiao   

  1. 1.Department of Gastrointestinal Medical Oncology,The Third Affiliated Hospital of Harbin Medical University,Harbin 150081;
    2.Prevention and Control Center of Tumor,Harbin Medical University,Harbin 150081
  • Received:2011-11-17 Online:2011-12-28 Published:2014-12-02

Abstract: Colorectal cancer is one of the most common malignancies in the world.Abnormal function of intestinal cells′ transmembrane signal transduction systems is associated with colorectal carcinogenesis,of which Ras/Raf/Mitogen-activated protein kinase(MAPK)cascade has been definitely and significantly involved.KRAS gene mutation leads the epidermal growth factor receptor(EGFR)′s initiation unnecessary for the activation of various genes in the downstream signal transduction pathways,which plays a major role in colorectal cancer′s genesis,progress therapy and prognosis.Therefore,testing KRAS gene status is essential in the clinical work,which demands for more precise of these processes.We sum up KRAS gene′s role in colorectal cancer and its mechanism,mutant incidence and testing methods.

CLC Number: